Investors with substantial losses have the potential to take the reins in a securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) under the ticker OM.
Class Period: August 1, 2022 – August 7, 2024
Lead Plaintiff Deadline: October 28, 2024
If considering a leadership role in the Outset Medical lawsuit, you can share your contact information at the designated webpage. For further details on your rights, consult with Charles H. Linehan of Glancy Prongay & Murray LLP.
The complaint asserts that during the Class Period, Defendants did not reveal to investors several critical points, leading to a claim that their communication around the Company’s status was substantially misleading.
Stay tuned for insights via LinkedIn, Twitter, or Facebook, and remember that participation in the class action requires no immediate action.
If you seek further information on your rights in connection to the pending class action lawsuit, reach out to Charles Linehan of GPM for guidance.
Note that according to applicable law and ethical rules, this press release may be viewed as Attorney Advertising in certain jurisdictions.
Contacts: Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
Follow the link to view original content and download multimedia: https://www.prnewswire.com/news-releases/om-investors-have-opportunity-to-lead-outset-medical-inc-securities-fraud-lawsuit-302248060.html
SOURCE Glancy Prongay & Murray LLP
